Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2015	Jun. 30, 2014
Current assets:
Cash	$ 71	$ 451
Accounts receivable, net	2,638	2,179
Inventories	5,778	5,698
Investment in iBio, Inc.	501	532
Other current assets	334	306
Total current assets	9,322	9,166
Intangible assets, net	743	880
Property and equipment, net	1,373	1,239
Security deposits and other assets	185	298
Total assets	11,623	11,583
Current liabilities:
Advances under revolving credit facility	4,462	4,121
Accounts payable (includes $290 and $184 due to a related party for 2015 and 2014)	5,148	5,635
Accrued expenses and other current liabilities	1,536	1,309
Current portion of long term debt	719	588
Total current liabilities	11,865	11,653
Long term debt	3,942	4,359
Subordinated convertible note, net - CD Financial, LLC	5,120	5,009
Derivative liabilities	12	717
Total liabilities	$ 20,939	$ 21,738
Commitments and contingencies
Stockholders' deficiency:
Common Stock, par value $0.002 per share; shares authorized 50,000,000; shares issued and outstanding were 21,140,074 and 21,105,174, respectivley	$ 42	$ 42
Additional paid-in-capital	44,676	44,572
Accumulated deficit	(53,935)	(54,670)
Less: Treasury stock, at cost, 34,900 shares	(99)	(99)
Total stockholders' deficiency	(9,316)	(10,155)
Total liabilities and stockholders' deficiency	$ 11,623	$ 11,583